ATE429913T1 - Synergistische zusammensetzungen mit analgetischen eigenschaften die eine n- acetylierte 4-hydroxyphenylamine derivate enthalten - Google Patents

Synergistische zusammensetzungen mit analgetischen eigenschaften die eine n- acetylierte 4-hydroxyphenylamine derivate enthalten

Info

Publication number
ATE429913T1
ATE429913T1 AT03789740T AT03789740T ATE429913T1 AT E429913 T1 ATE429913 T1 AT E429913T1 AT 03789740 T AT03789740 T AT 03789740T AT 03789740 T AT03789740 T AT 03789740T AT E429913 T1 ATE429913 T1 AT E429913T1
Authority
AT
Austria
Prior art keywords
analgesic
acetylate
contain
derivatives
analgesic properties
Prior art date
Application number
AT03789740T
Other languages
English (en)
Inventor
Nicolas Bazan
Carlos Sunkel
Julio Builla
Dennis Paul
Original Assignee
Univ Louisiana State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisiana State filed Critical Univ Louisiana State
Application granted granted Critical
Publication of ATE429913T1 publication Critical patent/ATE429913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT03789740T 2002-11-12 2003-11-12 Synergistische zusammensetzungen mit analgetischen eigenschaften die eine n- acetylierte 4-hydroxyphenylamine derivate enthalten ATE429913T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/292,105 US6864271B2 (en) 2002-11-12 2002-11-12 Synergistic combinations including N-acylated 4-hydroxyphenylamine derivatives
PCT/US2003/036039 WO2004043460A1 (en) 2002-11-12 2003-11-12 Synergistic combinations with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives

Publications (1)

Publication Number Publication Date
ATE429913T1 true ATE429913T1 (de) 2009-05-15

Family

ID=32229373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789740T ATE429913T1 (de) 2002-11-12 2003-11-12 Synergistische zusammensetzungen mit analgetischen eigenschaften die eine n- acetylierte 4-hydroxyphenylamine derivate enthalten

Country Status (9)

Country Link
US (1) US6864271B2 (de)
EP (2) EP2074996A1 (de)
JP (1) JP2006508137A (de)
AT (1) ATE429913T1 (de)
AU (1) AU2003294259B2 (de)
CA (1) CA2509252A1 (de)
DE (1) DE60327466D1 (de)
ES (1) ES2325369T3 (de)
WO (1) WO2004043460A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246058A1 (de) * 1997-09-04 2010-11-03 Novoneuron, Inc. Noribogain zur Behandlung von Schmerzen und Drogenabhängigheit
US7064140B2 (en) * 2002-11-12 2006-06-20 Carlos Sunkel Synergistic combinations including N-acylated 4-Hydroxyphenylamine derivatives and caffeine
US8026266B2 (en) 2005-11-08 2011-09-27 Arcion Therapeutics, Inc. Treatment of length dependent neuropathy
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
UA111065C2 (uk) 2010-07-23 2016-03-25 Демеркс, Інк. Композиції норибогаїну
EP2481740B1 (de) 2011-01-26 2015-11-04 DemeRx, Inc. Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA2855994A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
CA2858721C (en) 2011-12-11 2021-03-16 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
WO2014098877A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562110A (en) * 1896-06-16 Relasting-machine
US554636A (en) * 1896-02-11 Exercising-iviachine
US4599342A (en) 1984-01-16 1986-07-08 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4681897A (en) 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US6127352A (en) * 1988-02-01 2000-10-03 Uribe; Jose R. Pharmaceutical compositions with analgesics containing codeine
KR100243956B1 (ko) * 1991-09-06 2000-03-02 랄프 알. 팔로 트라마돌 물질 및 아세트아미노펜을 포함하는 통증 치료용 약제학적 조성물
US5554636A (en) * 1995-04-21 1996-09-10 Lsu Medical Center Foundation N-acylated 4-hydroxphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
US5840731A (en) 1995-08-02 1998-11-24 Virginia Commonwealth University Pain-alleviating drug composition and method for alleviating pain
US6048540A (en) 1997-01-29 2000-04-11 Chong Kun Dang Corp. Acetamenophen composition with reduced liver toxicity
FR2770131A1 (fr) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US6143278A (en) * 1998-02-23 2000-11-07 Elkhoury; George F. Topical application of opioid analgesic drugs such as morphine
GB9804885D0 (en) * 1998-03-06 1998-04-29 Merck Sharp & Dohme Therapeutic combination
WO2001078681A1 (en) * 2000-04-17 2001-10-25 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump

Also Published As

Publication number Publication date
WO2004043460A1 (en) 2004-05-27
US20040092541A1 (en) 2004-05-13
EP1572204B1 (de) 2009-04-29
AU2003294259A1 (en) 2004-06-03
DE60327466D1 (de) 2009-06-10
US6864271B2 (en) 2005-03-08
EP2074996A1 (de) 2009-07-01
ES2325369T3 (es) 2009-09-02
JP2006508137A (ja) 2006-03-09
AU2003294259B2 (en) 2008-12-18
EP1572204A1 (de) 2005-09-14
CA2509252A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
ATE429913T1 (de) Synergistische zusammensetzungen mit analgetischen eigenschaften die eine n- acetylierte 4-hydroxyphenylamine derivate enthalten
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
ATE494899T1 (de) Zusammensetzung bestehend aus phy906 und chemotherapeutika
BR0212019A (pt) Formas de dosagem, métodos para o tratamento da dor, métodos de preparação de uma forma de dosagem e métodos para impedir o abuso de uma forma de dosagem
MXPA05012350A (es) Antagonistas rage como agentes para la amiloidosis inversa y enfermedades asociadas con la misma.
DE60043318D1 (de) Synergistische kombination von pumafentrine und salmeterol
EP1539234A4 (de) Verfahren zur prävention oder behandlung von zellmalignität durch verabreichung von cd2-antagonisten
BRPI0113042B8 (pt) composto da fórmula ou um seu solvato fisiologicamente aceitável, uso do mesmo, composição farmacêutica, formulação farmacêutica, método para o tratamento de um indivíduo humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para preparar um composto ou um seu solvato
BR0313747A (pt) Inibidores de transcriptase reversa de não-nucleosìdeo
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR0307058A (pt) N-óxidos de derivados de n-fenil-2-pirimidina-amina
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
BRPI0407616A (pt) composto, composição farmacêutica, método para bloquear uma combinação de receptor de mu, capa, delta (heterodìmero) deste em mamìferos, método para tratar ou prevenir obesidade e doenças relacionadas, uso de um composto, e método de suprimir o apetite em um paciente em necessidade deste"
EA200200306A1 (ru) Трициклические ингибиторы поли(адф-рибозо)полимераз
ATE442135T1 (de) 5ht2c-rezeptor-modulator-zusammensetzungen und anwendungsverfahren
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
BR0207978A (pt) N-but-3enil norbuprenorfina e métodos de uso
PL377715A1 (pl) Antagoniści CCR1 do leczenia między innymi demielizacyjnej choroby zapalnej
GEP20063869B (en) Novel cyclohexyl sulphones
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
BRPI0414448A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e um agonista/antagonista de estrogênio
ATE409478T1 (de) Synergistische kombinationen enthaltend n- acylierte 4-hydroxyphenylamin derivate und koffein
CY1111900T1 (el) Θεραπεια του νευροπαθητικου πονου με ανταγωνιστες υποδοχεα ν-μεθυλ-d-ασπαρτικων (nmda)
DE50203154D1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
BR0113886A (pt) Composição, composição farmacêutica, tratamento de combinação para prevenir ou inibir a geração ou atividade de trombina num paciente, método para inibir ou prevenir a geração ou atividade de trombina num paciente, uso de uma composição ou tratamento de combinação, uso de uma composição, uso e kit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties